在糖尿病预防计划中,微RNA与体重之间的纵向关联
Elena Flowers1,2, Benjamin Stroebel1, Kimberly A Lewis1
1Department of Physiological Nursing, University of California, San Francisco, San Francisco, CA, United States.
Frontiers in endocrinology
|October 3, 2024
概括
循环中的微RNA与随时间的体重变化有关. 这些microRNAs可能会提供有关肥胖和疾病风险的原因的见解.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 代谢疾病 代谢疾病
背景情况:
- 循环中的微RNAs (miRNAs) 与超重和肥胖有关.
- 有限的研究区分了横截面的关联与前性风险标志物.
研究的目的:
- 为了评估循环miRNA和体重之间的纵向关系.
- 在糖尿病预防计划试验中调查miRNA与体重变化的关联.
主要方法:
- 分析了150名参与者的血样本,使用了Fireplex Assay.
- 在纵向分析中采用了通用线性混合模型和逻辑回归.
- 评估基线,第一年和第二年与体重变化相关的miRNA水平.
主要成果:
- 七个miRNAs (miR-126,miR-15a,miR-192,miR-23a,miR-27a) 与超过2年的体重有关.
- 在多次比较后,miR-197和miR-320a仍然显著.
- 基线let-7f,miR-17和miR-320c与2年后3%的体重减轻有关.
结论:
- 提供了循环miRNA与体重之间纵向关系的证据.
- 表明miRNAs可能为超重和肥胖的病因提供了洞察力.
- 强调需要进一步研究miRNA生物标志物用于体重管理和疾病预防.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


